# Auxilium

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/auxilium

- Industry: Pharmaceuticals
- Headquarters: Malvern, US
- Website: www.auxilium.com
- Total disclosed funding: $71M
- Latest round: Series D (Nov 6, 2003)
- Investors on record: 9

## About

Auxilium is a healthcare technology company focused on developing innovative solutions that enhance patient care and streamline healthcare delivery processes, primarily through advanced medical technology products.Auxilium is engaged in improving patient outcomes with a focus on chronic conditions. The company is headquartered in Malvern, US. As of July 23, 2004, Auxilium completed an IPO, raising USD 41.3 mn from the sale of 5.5 million shares at USD 7.5 each.Auxilium specializes in innovative medical technology products aimed at enhancing diagnostic accuracy and therapeutic efficacy for healthcare providers, including hospitals and outpatient facilities. Their offerings are tailored to the needs of healthcare professionals and patients across North America and Europe, addressing critical challenges in patient care and improving overall healthcare delivery.The company generates income through a combination of direct sales and partnerships with healthcare providers, operating under a model that supports both B2B and direct-to-consumer engagements, ensuring flexible client interactions.

## Funding rounds

- Series D, Nov 6, 2003, $43M — OrbiMed Advisors, SCP Partners, Sprout Group, Schroder Ventures, Aisling Capital, BB Biotech, Lehman Brothers, CIP Capital
- Series B, Nov 8, 2001, $28M — SCP Partners, Collins Stewart, Schroder Ventures, Aisling Capital, Lehman Brothers

## Investors

- SCP Partners (https://capitalatlas.ai/funds/scp-partners) — Series B, Series D
- Collins Stewart (https://capitalatlas.ai/funds/collins-stewart) — Series B
- Schroder Ventures (https://capitalatlas.ai/funds/schroder-ventures) — Series B, Series D
- Aisling Capital (https://capitalatlas.ai/funds/aisling-capital) — Series B, Series D
- Lehman Brothers (https://capitalatlas.ai/funds/lehman-brothers) — Series B, Series D
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series D
- Sprout Group (https://capitalatlas.ai/funds/sprout-group) — Series D
- BB Biotech (https://capitalatlas.ai/funds/bb-biotech) — Series D
- CIP Capital (https://capitalatlas.ai/funds/cip-capital) — Series D